Sarah Ford | April 18, 2014
Researcher Examines Impact of Extra Chromosome on Acute Myeloid Leukemia
David Gordon, MD, PhD at Dana Farber Cancer Institute is a CureSearch Young Investigator examining the impact of trisomy 8 on acute myeloid leukemia (AML). Of the 500 children diagnosed with AML each year, between 10-20% of an extra chromosome 8, called trisomy 8.
Dr. Gordon suspects that trisomy 8 contributes to the creation of cancerous cells because certain genes are expressed when an abnormal number of chromosomes are present. Using three cell lines he previously developed, Dr. Gordon spent the first year of his CureSearch grant screening the cell lines for new AML target genes and investigating the impact of trisomy 8 in blood cell development.
In the coming year, Dr. Gordon will explore how these genes, and their interaction with trisomy 8, lead to the development of AML.
Get Resources and Insights Straight To Your Inbox
Explore More Articles
Minority Mental Health Awareness Month
July is Minority Mental Health Awareness Month, a time dedicated to raising awareness about the unique mental health challenges faced by minority communities. It’s an…
Read Article
International Self Care Day
Today, July 24, 2025, we celebrate International Self Care Day, a day dedicated to promoting self-care practices and their numerous benefits for physical, mental, and…
Read Article
How the “Big Beautiful Bill” Will Impact Individual Giving and Employer-Sponsored Workplace Giving Programs
The One Big Beautiful Bill was signed into law on July 4, 2025, introducing a range of provisions that will affect how individuals, companies, and…
Read ArticleGet Resources and Insights Straight To Your Inbox
Receive our monthly/bi-monthly newsletter filled with information about causes, nonprofit impact, and topics important for corporate social responsibility and employee engagement professionals, including disaster response, workplace giving, matching gifts, employee assistance funds, volunteering, scholarship award program management, grantmaking, and other philanthropic initiatives.
